Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06857006 · ClinicalTrials.gov registry record · NA
Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
A NA study of Brain Metastases, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06857006 is a NA study of Brain Metastases that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 180 participants, below the 210-participant average among 67 other Brain Metastases trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06857006, a NA study of Brain Metastases, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Radiosurgery is the use of a focal high dose of radiation therapy to ablate or kill a tumor. This trial will enroll patients with brain metastases 4 cm or less in greatest diameter and will compare 0mm margin to a 2mm margin for treatment.
Conditions Studied
Interventions
- PROCEDURE brain metastases radiosurgery
Study Locations (1)
Alabama
- University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2028-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06857006
The ClinicalTrials.gov registry entry for NCT06857006 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 67 other Brain Metastases trials with a reported enrollment target (14% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Metastases appearing as the primary indexed condition, and to 1 intervention - of which brain metastases radiosurgery is the first listed.
NCT06857006 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT06857006 about?
NCT06857006 is a clinical study titled "Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases". Radiosurgery is the use of a focal high dose of radiation therapy to ablate or kill a tumor. This trial will enroll patients with brain metastases 4 cm or less in greatest diameter and will compare 0mm margin to a 2mm margin for treatment.
What is the current status of trial NCT06857006?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-04-08. Estimated completion is 2028-08.
What conditions does trial NCT06857006 study?
This clinical trial studies the following conditions: Brain Metastases.
What interventions are being tested in trial NCT06857006?
The interventions under investigation include: brain metastases radiosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT06857006?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06857006 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
RECRUITING · NA
-
REMASTer: REcurrent Brain Metastases After SRS Trial
RECRUITING · NA
-
Development of MRF for Characterization of Brain Tumors After Radiotherapy
RECRUITING · NA
-
MeDex: No Perioperative Dexamethasone in Brain Metastases
RECRUITING · NA
-
A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.